In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom's (UK's) withdrawal from the European Union (EU) and the Agency's...
Thursday, August 3, 2017 | Read More
Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting. Sentry plays a critical role in protecting temperature-sensitive product safety, identity, strength, purity and quality (SISPQ)...
Monday, July 31, 2017 | Read More
JULY 6, 2017 INDIANAPOLIS, IN Sentry BioPharma Services recently hosted a round table discussion with Congressman Trey Hollingsworth (IN 9th District) and representatives of BIO and the Indiana Health Industry Forum (IHIF). BIO organized the event as a part of its “535 Congressional Initiative 2017”. BIO...
Wednesday, July 12, 2017 | Read More
Sentry's Highly Protected Risk (HPR) facility is strategically located in Indianapolis, Indiana, the "Crossroads of America." This location enables Sentry to act as fast, expedient worldwide pharmaceutical distributors, providing a variety of built-in advantages for logistical efficiency.
Sentry's location is adjacent to Indianapolis International Airport, the eighth largest cargo airport in the U.S. The airport, just minutes away, serves 12 major airlines with more than 280 daily flights.
Four major interstates convene in Indianapolis (I-65, I-69, I-70 and I-74), providing one day driving access to 75% of all U.S. businesses.
Proximity to FedEx's 2nd largest hub enables Sentry to capitalize on late drop times, promoting effective west coast (U.S.) and global pharmaceutical distribution.